Mylan launches block deal to sell minority stake in Biocon for up to $363 million
The Viatris arm looks to offload 92 million equity shares, marking a financial exit following a series of biosimilar asset integrations.
What's Your Reaction?
Like
0
Dislike
0
Love
0
Funny
0
Wow
0
Sad
0
Angry
0
Comments (0)